Collegium Pharmaceutical (COLL) EBT Growth (3y) (2017 - 2026)
Collegium Pharmaceutical (COLL) EBT Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 21.00% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.19% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 3.60% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -29.91% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 10.08% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 39.40% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Collegium Pharmaceutical | 879.69 Mn | 730.37 Mn | 110.29 Mn | -40.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -40.28% |
| Mar 31, 2026 | 45.30% |
| Dec 31, 2025 | 78.91% |
| Sep 30, 2025 | 211.87% |
| Jun 30, 2025 | 65.85% |
| Mar 31, 2025 | 30.00% |
| Dec 31, 2024 | 34.70% |
| Sep 30, 2024 | 19.91% |
| Jun 30, 2024 | 38.34% |
| Mar 31, 2024 | 33.26% |
| Dec 31, 2023 | 85.97% |
| Sep 30, 2023 | 35.51% |
| Jun 30, 2023 | 28.93% |
| Mar 31, 2023 | -244.87% |
| Dec 31, 2022 | -52.40% |
| Sep 30, 2022 | 30.73% |
| Jun 30, 2022 | -12.15% |
| Mar 31, 2022 | -17.75% |
| Dec 31, 2021 | -84.48% |
| Sep 30, 2021 | 27.33% |